Recent data have demonstrated that Nrf2 activation can stimulate cancer cell migration and metastasis and Nrf2 deletion attenuates metastatic potential breast cancer cells suppressing RhoA GTPases activity (Zhang et al., 2016). This evidence concerns the gene NFE2L2 and breast carcinoma.